☰ Chemistry Tree

Malay Patra, Ph.D.

Affiliations:	2015-2018		Universität Zürich, Zürich, ZH, Switzerland
	2018-		Tata Institute of Fundamental Research, Mumbai, Maharashtra, India

Area:

Medicinal Chemistry, Drug Development, Drug Delivery, and Chemical Biology

Website:

https://patralab.wixsite.com/tifr/malay-patra

Google:

Mean distance: 10.92

S

N

B

C

P

Tree Publications Similar researchers PubMed Report error

Parents

Goutam Kumar Lahiri	research assistant	2005-2007	IIT Bombay
(M.Sc.)
Nils Metzler-Nolte	grad student	2007-2011	Ruhr-Universität Bochum
(Ph.D: 'Design, Synthesis, and Biological Evaluation of Organometallic Antibacterial Agents')
Gilles Gasser	post-doc	2011-2013	Universität Zürich
Stephen James Lippard	post-doc	2013-2015	MIT
Jason P. Holland	research scientist	2015-2018	Universität Zürich

Children

Shreyas P. Vaidya	grad student		Tata Institute of Fundamental Research
Shubhangi Das	grad student	2019-	Tata Institute of Fundamental Research
Shubhankar Gadre	post-doc	2019-	Tata Institute of Fundamental Research
Ritika Gautam	post-doc	2018-2019	Tata Institute of Fundamental Research

Collaborators

collaborator

2023-2023

Tata Insitute of Fundamental Research

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
Das S, Joshi P, Patra M. (2023) Necrosis-Inducing High-Valent Oxo-Rhenium(V) Complexes with Potent Antitumor Activity: Synthesis, Aquation Chemistry, Cisplatin Cross-Resistance Profile, and Mechanism of Action. Inorganic Chemistry
M M, Chhatar S, Gadre S, et al. (2023) Improving In Vivo Tumor Accumulation and Efficacy of Platinum Antitumor Agents by Electronic Tuning of the Kinetic Lability. Chemistry (Weinheim An Der Bergstrasse, Germany). e202302720
Gadre S, M M, Chakraborty G, et al. (2023) Development of a Highly Efficacious Dual Antitumor and Antiangiogenic Organoiridium Complex as a Potential Anti-Lung Cancer Agent. Journal of Medicinal Chemistry. 66: 13481-13500
Panda TR, Manikandan M, Vaidya SP, et al. (2023) The Power of Kinetic Inertness in Improving Platinum Anticancer Therapy by Circumventing Resistance and Ameliorating Nephrotoxicity. Angewandte Chemie (International Ed. in English). e202303958
Vaidya SP, Patra M. (2022) Platinum glycoconjugates: "Sweet bullets" for targeted cancer therapy? Current Opinion in Chemical Biology. 72: 102236
M M, Gadre S, Chhatar S, et al. (2022) Potent Ruthenium-Ferrocene Bimetallic Antitumor Antiangiogenic Agent That Circumvents Platinum Resistance: From Synthesis and Mechanistic Studies to Evaluation in Zebrafish. Journal of Medicinal Chemistry
Malankar GS, Shelar DS, M M, et al. (2022) A BOPHY based fluorescent probe for Hg NTe chelation. Dalton Transactions (Cambridge, England : 2003)
Gadre S, M M, Duari P, et al. (2022) A Rationally Designed Bimetallic Platinum (II)-Ferrocene Antitumor Agent Induces Non-Apoptotic Cell Death and Exerts in Vivo Efficacy. Chemistry (Weinheim An Der Bergstrasse, Germany)
Vaidya SP, Gadre S, Teja KR, et al. (2022) Challenges and opportunities in the development of metal-based anticancer theranostic agents. Bioscience Reports
Patra M, Vaidya SP. (2021) X-rays actuate anticancer drugs: Opening new vistas in prodrug therapy. Chembiochem : a European Journal of Chemical Biology

See more...